Assessment of Disease Feature and Treatment Pattern of Locally Advanced, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma in China (ADAPT-H&N)

Study identification

• EU PAS number:
  EUPAS103485
• Study ID:
  103486
• Official title and acronym:
  Assessment of Disease Feature and Treatment Pattern of Locally Advanced, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma in China (ADAPT-H&N)
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

Shanghai East Hospital Tongji University

Study timelines

Date when funding contract was signed

Actual:28/11/2022

Study start date

Planned:13/02/2023

Date of final study report

Planned:31/01/2024

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MSD (China) Holding Co., Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable